BC Platforms is a global leader in providing a powerful data and technology platform for personalized medicine and drug development, accelerating the translation of insights into clinical practice.
BCP’s global network of data partners includes several centers of excellence. We have developed these relationships over several years through implementing the technology infrastructure for several countries and European level Research Data Sharing Initiatives. (Finngen, OncoGuide, HDRUK Gateway, NHS England’s sub-national SDE program). Continuous data partner engagement means that BCP starts the engagement with strong foundational knowledge of what data is generally captured and how it is stored. It also allows for a rapid feasibility to enable a timely full study start for data collection and data delivery.
BC Platforms leverages its 26-year heritage in European healthcare data to provide secure and safe access to RWD from our Data Partner Network to our Life Sciences Industry clients. A particular strength is providing access to ex-US datasets, with a focus on the EU4 + UK, Japan and Singapore.
As a leading player in Secure Data Environment technology, BCP is able to instill confidence in data partners, which results in relatively quick access to data, and often enables access to sensitive data which would not be granted to companies working with more traditional approaches based on sending data between organisations. Experience and expertise in the collection, collation and curation of data across sites is also fundamental to a successful project in RWD.
Ethics approval and consent are interconnected processes that together ensure the ethical use of RWD in research. BCP’s deep understanding of the European regulatory framework guarantees adherence to data protection laws, including GDPR, while guiding the necessary procedures for obtaining ethical approvals and consent or consent waivers. Our expertise and data partner network relationships enable effective and efficient navigation of ethics and consent processes.

BC Platforms operates the Global Data Partner Network BCRQUEST.com, which provides access and analytics on genomic and clinical cohort data for drug developers currently providing access to over 16m subjects across five continents.

Our technology drives the infinite loop between personalized care and research discoveries, leveraging latest science, deep technical expertise, strategic partnerships, and harmonized, diverse data collections.

Our high performing platforms enable high throughput genomic data production, flexible data integration, secure data management, efficient analysis and interpretation of molecular and clinical information.

Founded in 1997 from an MIT Whitehead project spinoff, the Company has a strong scientific heritage underpinned by over 20 years of working in close collaboration with a network of leading researchers, developers, manufacturers and vendors. BC Platforms has global operations with its headquarters in Zurich, Switzerland, research and development in Espoo, Finland, and sales and marketing in Boston, USA, London, UK and Singapore. For more information, please visit www.bcplatforms.com.